Research Groups

Early Detection and Prevention - Prevention and Implementation Group

Previous Publications - All Publications 2016-2012

1. Costas L., Benavente Y., Olmedo-Requena R., Casabonne D., Robles C., Gonzalez-Barca E. M., de la Banda E., Alonso E., Aymerich M., Tardon A., Marcos-Gragera R., Gimeno-Vazquez E., Gomez-Acebo I., Papantoniou K., Castano-Vinyals G., Aragones N., Pollan M., Kogevinas M., de Sanjose S. (2016) Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study Int J Cancer; 139(9):1994-2000. PMID: 27416551

2. Combita A. L., Gheit T., Gonzalez P., Puerto D., Murillo R. H., Montoya L., Vorsters A., Van Keer S., Van Damme P., Tommasino M., Hernandez-Suarez G., Sanchez L., Herrero R., Wiesner C. (2016) Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia Cancer Prev Res (Phila); 9(9):766-71. PMID: 27417431

3. Talarico S., Safaeian M., Gonzalez P., Hildesheim A., Herrero R., Porras C., Cortes B., Larson A., Fang F. C., Salama N. R. (2016) Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage Helicobacter; 21(4):325-33. PMID: 26667241

4. Bruni L., Diaz M., Barrionuevo-Rosas L., Herrero R., Bray F., Bosch F. X., de Sanjose S., Castellsague X. (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis Lancet Glob Health; 4(7):e453-63. PMID: 27340003

5. Negulescu R. A., Catarino R., De Vuyst H., Undurraga-Malinverno M., Meyer-Hamme U., Alec M., Campana A., Vassilakos P., Petignat P. (2016) Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers Int J Gynaecol Obstet; 134(1):107-13. PMID: 27126908

6. Berthiller J., Straif K., Agudo A., Ahrens W., Bezerra Dos Santos A., Boccia S., Cadoni G., Canova C., Castellsague X., Chen C., Conway D., Curado M. P., Dal Maso L., Daudt A. W., Fabianova E., Fernandez L., Franceschi S., Fukuyama E. E., Hayes R. B., Healy C., Herrero R., Holcatova I., Kelsey K., Kjaerheim K., Koifman S., Lagiou P., La Vecchia C., Lazarus P., Levi F., Lissowska J., Macfarlane T., Mates D., McClean M., Menezes A., Merletti F., Morgenstern H., Muscat J., Olshan A. F., Purdue M., Ramroth H., Rudnai P., Schwartz S. M., Serraino D., Shangina O., Smith E., Sturgis E. M., Szeszenia-Dabrowska N., Thomson P., Vaughan T. L., Vilensky M., Wei Q., Winn D. M., Wunsch-Filho V., Zhang Z. F., Znaor A., Ferro G., Brennan P., Boffetta P., Hashibe M., Lee Y. C. (2016) Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis Int J Epidemiol; 45(3):835-45. PMID: 26228584

7. Harari A., Chen Z., Rodriguez A. C., Hildesheim A., Porras C., Herrero R., Wacholder S., Panagiotou O. A., Befano B., Burk R. D., Schiffman M. (2016) Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections J Infect Dis; 213(6):939-47. PMID: 26518044

8. Santesso N., Mustafa R. A., Schunemann H. J., Arbyn M., Blumenthal P. D., Cain J., Chirenje M., Denny L., De Vuyst H., Eckert L. O., Forhan S. E., Franco E. L., Gage J. C., Garcia F., Herrero R., Jeronimo J., Lu E. R., Luciani S., Quek S. C., Sankaranarayanan R., Tsu V., Broutet N. (2016) World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer Int J Gynaecol Obstet; 132(3):252-8. PMID: 26868062

9. Murillo R., Diaz S., Perry F., Poveda C., Pineros M., Sanchez O., Buitrago L., Gamboa O., Lozano T., Yu H., Wang C. Y., Duggan C., Thomas D. B., Anderson B. O. (2016) Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast-screening Int J Cancer; 138(3):705-13. PMID: 26264446

10. Beachler D. C., Kreimer A. R., Schiffman M., Herrero R., Wacholder S., Rodriguez A. C., Lowy D. R., Porras C., Schiller J. T., Quint W., Jimenez S., Safaeian M., Struijk L., Schussler J., Hildesheim A., Gonzalez P. (2016) Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection J Natl Cancer Inst; 108(1):. PMID: 26467666

11. Hernandez-Avila M., Torres-Ibarra L., Stanley M., Salmeron J., Cruz-Valdez A., Munoz N., Herrero R., Villasenor-Ruiz I. F., Lazcano-Ponce E. (2016) Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes Hum Vaccin Immunother; 12(1):30-8. PMID: 26211489

12. Armaroli P., Villain P., Suonio E., Almonte M., Anttila A., Atkin W. S., Dean P. B., de Koning H. J., Dillner L., Herrero R., Kuipers E. J., Lansdorp-Vogelaar I., Minozzi S., Paci E., Regula J., Tornberg S., Segnan N. (2015) European Code against Cancer, 4th Edition: Cancer screening Cancer Epidemiol; S139-52. PMID: 26596722

13. Minozzi S., Armaroli P., Espina C., Villain P., Wiseman M., Schuz J., Segnan N. (2015) European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations Cancer Epidemiol; S11-9. PMID: 26439654

14. Schuz J., Espina C., Villain P., Herrero R., Leon M. E., Minozzi S., Romieu I., Segnan N., Wardle J., Wiseman M., Belardelli F., Bettcher D., Cavalli F., Galea G., Lenoir G., Martin-Moreno J. M., Nicula F. A., Olsen J. H., Patnick J., Primic-Zakelj M., Puska P., van Leeuwen F. E., Wiestler O., Zatonski W. (2015) European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk Cancer Epidemiol; S1-10. PMID: 26164654

15. Villain P., Gonzalez P., Almonte M., Franceschi S., Dillner J., Anttila A., Park J. Y., De Vuyst H., Herrero R. (2015) European Code against Cancer 4th Edition: Infections and Cancer Cancer Epidemiol; S120-38. PMID: 26589774

16. Shimakawa Y., Lemoine M., Bottomley C., Njai H. F., Ndow G., Jatta A., Tamba S., Bojang L., Taal M., Nyan O., D'Alessandro U., Njie R., Thursz M., Hall A. J. (2015) Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia Liver Int; 35(10):2318-26. PMID: 25728498

17. Bryant D., Hibbitts S., Almonte M., Tristram A., Fiander A., Powell N. (2015) Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women Journal of Clinical Virology; 66-71. PMID: 25866341

18. Almonte M., Ferreccio C., Luciani S., Gonzales M., Delgado J.M., Santos C., Alvarez M., Cuzick J., Sasieni P. (2015) Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru PLoS. One; 10(1):e0115355.

19. Antilla A., Arbyn M, De Vuyst H., Dillner J., Dillner L., Franceschi S., Patnick J., Ronco G., Segnan N., Suonio E., Tornberg S., von Karsa L. (2015) European guidelines for quality assurance in cervical cancer screening ; .

20. Arrossi S., Thouyaret L., Herrero R., Campanera A., Magdaleno A., Cuberli M., Barletta P., Laudi R., Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial Lancet Glob. Health; 3(2):e85-e94. PMID: 25617202

21. Arrossi S., Thouyaret L., Laudi R., Marin O., Ramirez J., Paolino M., Herrero R., Campanera A. (2015) Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina Int J Cancer; 137(7):1709-1718.

22. Conway D.I., Brenner D.R., McMahon A.D., Macpherson L.M., Agudo A., Ahrens W., Bosetti C., Brenner H., Castellsague X., Chen C., Curado M.P., Curioni O.A., Dal Maso L., Daudt A.W., de Gois Filho J.F., D'Souza G., Edefonti V., Fabianova E., Fernandez L., Franceschi S., Gillison M., Hayes R.B., Healy C.M., Herrero R., Holcatova I., Jayaprakash V., Kelsey K., Kjaerheim K., Koifman S., La Vecchia C., Lagiou P., Lazarus P., Levi F., Lissowska J., Luce D., Macfarlane T.V., Mates D., Matos E., McClean M., Menezes A.M., Menvielle G., Merletti F., Morgenstern H., Moysich K., Muller H., Muscat J., Olshan A.F., Purdue M.P., Ramroth H., Richiardi L., Rudnai P., Schantz S., Schwartz S.M., Shangina O., Simonato L., Smith E., Stucker I., Sturgis E.M., Szeszenia-Dabrowska N., Talamini R., Thomson P., Vaughan T.L., Wei Q., Winn D.M., Wunsch-Filho V., Yu G.P., Zhang Z.F., Zheng T., Znaor A., Boffetta P., Chuang S.C., Ghodrat M., Amy Lee Y.C., Hashibe M., Brennan P. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries Int J Cancer; 136(5):1125-1139. PMID: 24996155

23. de Batlle J., Ferrari P., Chajes V., Park J.Y., Slimani N., McKenzie F., Overvad K., Roswall N., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Fagherazzi G., Katzke V., Kaaks R., Bergmann M.M., Trichopoulou A., Lagiou P., Trichopoulos D., Palli D., Sieri S., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., Peeters P.H., Hjartaker A., Engeset D., Weiderpass E., Sanchez S., Travier N., Sanchez M.J., Amiano P., Chirlaque M.D., Barricarte Gurrea A., Khaw K.T., Key T.J., Bradbury K.E., Ericson U., Sonestedt E., Van Guelpen B., Schneede J., Riboli E., Romieu I. (2015) Dietary folate intake and breast cancer risk: European prospective investigation into cancer and nutrition J Natl Cancer Inst; 107(1):367. PMID: 25505228

24. Gonzalez P., Hildesheim A., Herrero R., Katki H., Wacholder S., Porras C., Safaeian M., Jimenez S., Darragh T.M., Cortes B., Befano B., Schiffman M., Carvajal L., Palefsky J., Schiller J., Ocampo R., Schussler J., Lowy D., Guillen D., Stoler M.H., Quint W., Morales J., Avila C., Rodriguez A.C., Kreimer A.R. (2015) Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica Vaccine; 33(18):2141-2151. PMID: 25796338

25. Herrero R., Gonzalez P., Markowitz L.E. (2015) Present status of human papillomavirus vaccine development and implementation Lancet Oncol; 16(5):e206-e216. PMID: 25943065

26. Kreimer A.R., Struyf F., Del Rosario-Raymundo M.R., Hildesheim A., Skinner S.R., Wacholder S., Garland S.M., Herrero R., David M.P., Wheeler C.M. (2015) Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials Lancet Oncol; 16(7):775-786. PMID: 26071347

27. Lowy D.R., Herrero R., Hildesheim A., Participants in the IARC/NCI workshop on Primary Endpoints for Prophylactic HPV Vaccine Trials (2015) Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging Lancet Oncol; 16(5):e226-e233. PMID: 25943067

28. Panagiotou O.A., Befano B.L., Gonzalez P., Rodriguez A.C., Herrero R., Schiller J.T., Kreimer A.R., Schiffman M., Hildesheim A., Wilcox A.J., Wacholder S. (2015) Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial BMJ; h4358.

29. Park M.K., Park J.Y., Nicolas G., Paik H.Y., Kim J., Slimani N. (2015) Adapting a standardised international 24 h dietary recall methodology (GloboDiet software) for research and dietary surveillance in Korea Br. J Nutr; 113(11):1810-1818. PMID: 25899045

30. Porras C., Hildesheim A., Gonzalez P., Schiffman M., Rodriguez A.C., Wacholder S., Jimenez S., Quint W., Guillen D., Kreimer A.R., Herrero R. (2015) Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing J Natl Cancer Inst; 107(1):400. PMID: 25479804

31. Quesada P., Whitby D., Benavente Y., Miley W., Labo N., Chichareon S., Trong N., Shin H.R., Anh P.T., Thomas J., Matos E., Herrero R., Munoz N., Molano M., Franceschi S., de Sanjose S. (2015) Hepatitis C virus seroprevalence in the general female population from 8 countries J Clin. Virol; 89-93.

32. Toporcov T.N., Znaor A., Zhang Z.F., Yu G.P., Winn D.M., Wei Q., Vilensky M., Vaughan T., Thomson P., Talamini R., Szeszenia-Dabrowska N., Sturgis E.M., Smith E., Shangina O., Schwartz S.M., Schantz S., Rudnai P., Richiardi L., Ramroth H., Purdue M.P., Olshan A.F., Eluf-Neto J., Muscat J., Moyses R.A., Morgenstern H., Menezes A., McClean M., Matsuo K., Mates D., Macfarlane T.V., Lissowska J., Levi F., Lazarus P., La Vecchia C., Lagiou P., Koifman S., Kjaerheim K., Kelsey K., Holcatova I., Herrero R., Healy C., Hayes R.B., Franceschi S., Fernandez L., Fabianova E., Daudt A.W., Curioni O.A., Maso L.D., Curado M.P., Conway D.I., Chen C., Castellsague X., Canova C., Cadoni G., Brennan P., Boccia S., Antunes J.L., Ahrens W., Agudo A., Boffetta P., Hashibe M., Lee Y.C., Filho V.W. (2015) Risk factors for head and neck cancer in young adults: a pooled analysis in the INHANCE consortium Int. J Epidemiol; 44(1):169-185.

33. (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination Papillomavirus Research; 22-31.

34. Anantharaman D., Chabrier A., Gaborieau V., Franceschi S., Herrero R., Rajkumar T., Samant T., Mahimkar M.B., Brennan P., McKay J.D. (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India PLoS ONE; 9(2):e88240.

35. Bedoya A.M., Tate D.J., Baena A., Cordoba C.M., Borrero M., Pareja R., Rojas F., Patterson J.R., Herrero R., Zea A.H., Sanchez G.I. (2014) Immunosuppression in cervical cancer with special reference to arginase activity Gynecol. Oncol; 135(1):74-80.

36. Campos N.G., Burger E.A., Sy S., Sharma M., Schiffman M., Rodriguez A.C., Hildesheim A., Herrero R., Kim J.J. (2014) An updated natural history model of cervical cancer: derivation of model parameters Am J Epidemiol; 180(5):545-555.

37. Chen A.A., Heideman D.A., Boon D., Chen Z., Burk R.D., De Vuyst H., Gheit T., Snijders P.J., Tommasino M., Franceschi S., Clifford G.M. (2014) Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer Virology; 356-362.

38. Combes J.D., Pawlita M., Waterboer T., Hammouda D., Rajkumar T., Vanhems P., Snijders P., Herrero R., Franceschi S., Clifford G. (2014) Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer Int J Cancer; 135(10):2453-2461.

39. De Vuyst H., Mugo N.R., Franceschi S., McKenzie K., Tenet V., Njoroge J., Rana F.S., Sakr S.R., Snijders P.J., Chung M.H. (2014) Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia Grade 2/3 in HIV-Positive Women in Kenya PLoS ONE; 9(10):e111037.

40. Guevara E., Baena A., Almonte M., Salaza J.E., Gaviria A., Sanchez G.I. (2014) Revista Facultad Nacional de Salud Publica; 32(2):54-60.

41. Herrero R., Park J.Y., Forman D. (2014) The fight against gastric cancer - the IARC Working Group report Best. Pract. Res Clin Gastroenterol; 28(6):1107-1114.

42. Herrero R., Parsonnet J., Greenberg E.R. (2014) Prevention of gastric cancer JAMA; 312(12):1197-1198.

43. Lang Kuhs K.A., Gonzalez P., Rodriguez A.C., Van Doorn L.J., Schiffman M., Struijk L., Chen S., Quint W., Lowy D.R., Porras C., DelVecchio C., Jimenez S., Safaeian M., Schiller J.T., Wacholder S., Herrero R., Hildesheim A., Kreimer A.R. (2014) Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial J Infect Dis; 210(12):1890-1899.

44. Lang Kuhs K.A., Porras C., Schiller J.T., Rodriguez A.C., Schiffman M., Gonzalez P., Wacholder S., Ghosh A., Li Y., Lowy D.R., Kreimer A.R., Poncelet S., Schussler J., Quint W., Van Doorn L.J., Sherman M.E., Sidawy M., Herrero R., Hildesheim A., Safaeian M. (2014) Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates Am. J. Epidemiol; 180(6):599-607.

45. Lazcano-Ponce E., Stanley M., Munoz N., Torres L., Cruz-Valdez A., Salmeron J., Rojas R., Herrero R., Hernandez-Avila M. (2014) Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Vaccine; 32(6):725-732.

46. Leoncini E., Ricciardi W., Cadoni G., Arzani D., Petrelli L., Paludetti G., Brennan P., Luce D., Stucker I., Matsuo K., Talamini R., La Vecchia C., Olshan A.F., Winn D.M., Herrero R., Franceschi S., Castellsague X., Muscat J., Morgenstern H., Zhang Z.F., Levi F., Dal Maso L., Kelsey K., McClean M., Vaughan T.L., Lazarus P., Purdue M.P., Hayes R.B., Chen C., Schwartz S.M., Shangina O., Koifman S., Ahrens W., Matos E., Lagiou P., Lissowska J., Szeszenia-Dabrowska N., Fernandez L., Menezes A., Agudo A., Daudt A.W., Richiardi L., Kjaerheim K., Mates D., Betka J., Yu G.P., Schantz S., Simonato L., Brenner H., Conway D.I., Macfarlane T.V., Thomson P., Fabianova E., Znaor A., Rudnai P., Healy C., Boffetta P., Chuang S.C., Lee Y.C., Hashibe M., Boccia S. (2014) Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium Eur J Epidemiol; 29(1):35-48.

47. Park J.Y., von Karsa L., Herrero R. (2014) Prevention strategies for gastric cancer: a global perspective Clin Endosc; 47(6):478-489.

48. Robbins H.A., Kemp T.J., Porras C., Rodriguez A.C., Schiffman M., Wacholder S., Gonzalez P., Schiller J., Lowy D., Poncelet S., Esser M., Matys K., Hildesheim A., Pinto L.A., Herrero R., Safaeian M. (2014) Comparison of antibody responses to human papillomavirus vaccination as measured by three assays Front Oncol; 328.

49. Robbins H.A., Li Y., Porras C., Pawlita M., Ghosh A., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Gonzalez P., Schiller J., Lowy D., Esser M., Matys K., Quint W., Van Doorn L.J., Herrero R., Pinto L.A., Hildesheim A., Waterboer T., Safaeian M. (2014) Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus BMC. Infect Dis; 120.

50. Robbins H.A., Waterboer T., Porras C., Kemp T.J., Pawlita M., Rodriguez A.C., Wacholder S., Gonzalez P., Schiller J.T., Lowy D.R., Esser M., Matys K., Poncelet S., Herrero R., Hildesheim A., Pinto L.A., Safaeian M. (2014) Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay Hum. Vaccin. Immunother; 10(10):2965-2974.

51. Rollan A., Arab J.P., Camargo M.C., Candia R., Harris P., Ferreccio C., Rabkin C.S., Gana J.C., Cortes P., Herrero R., Duran L., Garcia A., Toledo C., Espino A., Lustig N., Sarfatis A., Figueroa C., Torres J., Riquelme A. (2014) Management of Helicobacter pylori infection in Latin America: A Delphi technique-based consensus World J Gastroenterol; 20(31):10969-10983.

52. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., Kitchener H., Segnan N., Gilham C., Giorgi-Rossi P., Berkhof J., Peto J., Meijer C.J. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet; 383(9916):524-532.

53. Bedoya A.M., Jaramillo R., Baena A., Castano J., Olaya N., Zea A.H., Herrero R., Sanchez G.I. (2013) Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer Cancer Microenviron; 6(1):69-77.

54. De Vuyst H., Chung M.H., Baussano I., Mugo N.R., Tenet V., van Kemenade F.J., Rana F.S., Sakr S.R., Meijer C.J., Snijders P.J., Franceschi S. (2013) Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya Int. J Cancer; 133(6):1441-1446.

55. Herrero R. (2013) HPV and Cervical Cancer ; .

56. Herrero R., Quint W., Hildesheim A., Gonzalez P., Struijk L., Katki H.A., Porras C., Schiffman M., Rodriguez A.C., Solomon D., Jimenez S., Schiller J.T., Lowy D.R., Van Doorn L.J., Wacholder S., Kreimer A.R. (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS ONE; 8(7):e68329.

57. Lang Kuhs K.A., Gonzalez P., Struijk L., Castro F., Hildesheim A., Van Doorn L.J., Rodriguez A.C., Schiffman M., Quint W., Lowy D.R., Porras C., DelVecchio C., Katki H.A., Jimenez S., Safaeian M., Schiller J., Solomon D., Wacholder S., Herrero R., Kreimer A.R. (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica J Infect. Dis; 208(10):1643-1652.

58. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. (2013) HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays PLoS ONE; 8(1):e53067.

59. Morgan D.R., Torres J., Sexton R., Herrero R., Salazar-Martinez E., Greenberg E.R., Bravo L.E., Dominguez R.L., Ferreccio C., Lazcano-Ponce E.C., Meza-Montenegro M.M., Pena E.M., Pena R., Correa P., Martinez M.E., Chey W.D., Valdivieso M., Anderson G.L., Goodman G.E., Crowley J.J., Baker L.H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities JAMA; 309(6):578-586.

60. Nascimento C., De Vuyst H. (2013) Prevalence and type distribution of HPV in carcinoma and intraepithelial neoplasia of the vulva and vagina: a meta-analysis HPV Today; 12-13.

61. Park J.Y., Forman D., Greenberg E.R., Herrero R. (2013) Helicobacter pylori Eradication in the Prevention of Gastric Cancer: Are More Trials Needed? Curr Oncol Rep; 15(6):517-525.

62. Porras C., Nodora J., Sexton R., Ferreccio C., Jimenez S., Dominguez R.L., Cook P., Anderson G., Morgan D.R., Baker L.H., Greenberg E.R., Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) Cancer Causes Control; 24(2):209-215.

63. Rodriguez A.C., Solomon D., Herrero R., Hildesheim A., Gonzalez P., Wacholder S., Porras C., Jimenez S., Schiffman M. (2013) Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment Am. J Epidemiol; 178(5):752-760.

64. Safaeian M., Kemp T.J., Pan D.Y., Porras C., Rodriguez A.C., Schiffman M., Cortes B., Katki H., Wacholder S., Schiller J.T., Gonzalez P., Penrose K., Lowy D.R., Quint W., Van Doorn L.J., Herrero R., Hildesheim A., Pinto L.A. (2013) Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial Hum Vaccin. Immunother; 9(7):1399-1406.

65. Safaeian M., Porras C., Pan Y., Kreimer A., Schiller J.T., Gonzalez P., Lowy D.R., Wacholder S., Schiffman M., Rodriguez A.C., Herrero R., Kemp T., Shelton G., Quint W., Van Doorn L.J., Hildesheim A., Pinto L.A. (2013) Durable antibody responses following one dose of the bivalent human papillomavirus l1 virus-like particle vaccine in the costa rica vaccine trial Cancer Prev Res. (Phila); 6(11):1242-1250.

66. Torres J., Correa P., Ferreccio C., Hernandez-Suarez G., Herrero R., Cavazza-Porro M., Dominguez R., Morgan D. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America Cancer Causes Control; 24(2):249-256.

67. Castro F.A., Quint W., Gonzalez P., Katki H.A., Herrero R., Van Doorn L.J., Schiffman M., Struijk L., Rodriguez A.C., Del Vecchio C., Lowy D.R., Porras C., Jimenez S., Schiller J., Solomon D., Wacholder S., Hildesheim A., Kreimer A.R. (2012) Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica J Infect Dis; 206(7):1103-1110.

68. Gonzalez P., Cortes B., Quint W., Kreimer A.R., Porras C., Rodriguez A.C., Jimenez S., Herrero R., Struijk L., Hildesheim A., Melchers W. (2012) Evaluation of the FTA carrier device for human papillomavirus testing in developing countries J Clin Microbiol; 50(12):3870-3876.

69. Kemp T.J., Safaeian M., Hildesheim A., Pan Y., Penrose K.J., Porras C., Schiller J.T., Lowy D.R., Herrero R., Pinto L.A. (2012) Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix((R)) Vaccine; 31(1):165-170.

70. Kemp T.J., Safaeian M., Miner S., Williams M.C., Rodriguez A.C., Herrero R., Hildesheim A., Pinto L.A. (2012) Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels Front Oncol; 61.

71. Kreimer A.R., Schiffman M., Herrero R., Hildesheim A., Gonzalez P., Burk R.D., Porras C., Sherman M.E., Demuth F., Cheung L., Bratti C., Cecilia Rodriguez A. (2012) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment Int J Cancer; 131(1):211-218.

72. Li Q., Chuang S.C., Eluf-Neto J., Menezes A., Matos E., Koifman S., Wunsch-Filho V., Fernandez L., Daudt A.W., Curado M.P., Winn D.M., Franceschi S., Herrero R., Castellsague X., Morgenstern H., Zhang Z.F., Lazarus P., Muscat J., McClean M., Kelsey K.T., Hayes R.B., Purdue M.P., Schwartz S.M., Chen C., Benhamou S., Olshan A.F., Yu G., Schantz S., Ferro G., Brennan P., Boffetta P., Hashibe M. (2012) Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium Int J Cancer; 131(7):1686-1699.

73. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Cheung L., Wacholder S., Burk R.D. (2012) Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3 Int J Cancer; 131(8):1874-1881.

74. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., Van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. (2012) Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naive Women in HPV Vaccine Trials Cancer Epidemiol Biomarkers Prev; 21(9):1547-1554.

75. Santesso N., Schunemann H., Blumenthal P., De Vuyst H., Gage J., Garcia F., Jeronimo J., Lu R., Luciani S., Quek S.C., Awad T., Broutet N. (2012) World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia Int J Gynaecol Obstet; 118(2):97-102.